Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic – StreetInsider.com
Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic StreetInsider.com
Browsing Tag
Biopharma
RedHill Biopharma reports that the opaganib mechanism is not affected by viral spike protein…
RedHill Biopharma reports that the opaganib mechanism is unaffected by viral spike protein mutations, including Omicron mutations, from The Mountaineer
RedHill Biopharma Reports Top-Line Data From Phase 2/3 Study Of Opaganib In Serious COVID-19…
RedHill Biopharma Reports Top Line Data From Phase 2/3 Study Of Opaganib In Serious COVID-19 Patients Johnson City Press (Subscription)
RedHill Biopharma announces presentation of positive oral opaganib Phase 2 data in COVID-19 –…
RedHill Biopharma Announces Presentation of Positive Phase 2 Data for Oral Opaganib in COVID-19
RedHill Biopharma Completes Oral Opaganib Phase 2/3 COVID-19 Study Recruitment – Johnson City…
RedHill Biopharma Completes Oral Opaganib Phase 2/3 COVID-19 Trial Registration Johnson City Press (Subscription)
RedHill Biopharma Receives U.S. Patent Filing Grants for Opaganib and RHB-107 for COVID-19 –…
RedHill Biopharma Receives U.S. Patent Filing Approvals for Opaganib and RHB-107 for COVID-19 PRNewswire